Overview

Compare S-1 for 6 Months to 1 Year as Adjuvant Chemotherapy After D2 Resection in Patients With Gastric Cancer Staged II , IIIA or IIIB.

Status:
Withdrawn

Trial end date:
2023-03-01

Target enrollment:

Participant gender:

Summary

The study aims to compare the efficacy and safety of S-1 for 6 months versus S-1 for 1 year as adjuvant chemotherapy after D2 resection in patients with gastric cancer. Hypothesis: For gastric patients after D2 resection, S-1 for 6 months shows non-inferiority to S-1 for 1 year in disease free survival(DFS), overall survival (OS) and safety.

Phase:

Phase 3

Details

Lead Sponsor:

Fudan University
Sun Yat-sen University

Collaborators:

Anhui Provincial Hospital
Anqing Municipal Hospital
First Affiliated Hospital of Wannan Medical College
Guangdong Provincial Hospital of Traditional Chinese Medicine
Lishui hospital of Zhejiang University
Shenzhen People's Hospital
Sun Yat-sen University
The First Affiliated Hospital of Anhui Medical University
The First Affiliated Hospital of Guangdong Pharmaceutical University
Yuebei People's Hospital